Dr. Anvar Babaev, MD

Dr. Babaev practices at NYU Langone - Tisch Hospital in New York, New York.

Dr. Babaev's NPI, 1942294673, was assigned on September 8, 2005. Dr. Babaev graduated from Tajik State Medical University in 1984. Dr. Babaev holds New York license 218777.

Dr. Babaev's primary practice is NYU Langone - Tisch Hospital, at 550 1st Ave, New York, NY 10016 in New York County. The practice phone is (212) 263-1481.

Dr. Babaev's primary practice is NYU Langone - Tisch Hospital in New York, New York. Dr. Babaev is also affiliated with Tisch Hospital. The medical group on file is NYU Langone Orthopedic Surgery Associates.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Babaev practices. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Babaev's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Babaev is board certified in cardiovascular disease by the American Board of Internal Medicine. Dr. Babaev is licensed in New York.

Dmand AI lists aneurysm, angioplasty, atrial fibrillation and flutter, cardiac catheterization, cardiomyopathy, cerebrovascular disease, chronic embolism thrombosis and chronic hypertension among the conditions Dr. Babaev treats.

CMS data shows 1,980 Medicare services from Dr. Babaev across 19 procedure codes in 2024, for 523 Medicare patients. Medicare paid $234,557 for them.

CMS counts 523 Medicare patients who saw Dr. Babaev in 2024. The largest group is 75 to 84, with 238 patients. 75% of them have arthritis, and 75% have diabetes. 85% are also on Medicaid. Their average risk score is 2.31, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Babaev's median patient age at 71, with 38% women.

In 2024, Dr. Babaev wrote 4,117 Medicare Part D claims for 403 patients. 81% of them were for generic drugs. CMS names the drug for 3,921 of them, across 45 drugs with 11 or more claims each, at $432,319 in total drug cost. In 2023, CMS named 4,139 claims across 50 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Babaev for performance year 2024, reported as part of a group. Dr. Babaev accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 123 procedures of coronary angioplasty and stenting by Dr. Babaev, more than 98% of the clinicians it reports for that procedure.

Dmand AI links 31 papers to Dr. Babaev, published from 2010 to 2025. 2016 was the busiest year, with 4. The most frequent topics are Femoral Artery, Peripheral Arterial Disease and Angioplasty, Balloon. Dr. Babaev has published most often in J Invasive Cardiol. Dr. Babaev's most frequent co-authors are Michael Attubato, MD, Frederick Feit, MD and Farzan M. Gorgani, DO.

Dmand AI links Dr. Babaev to 8 clinical trials, 2 of them phase 3 studies. 1 is still active or recruiting. Conditions studied include Peripheral Arterial Disease, Peripheral Vascular Diseases and Chronic Limb-Threatening Ischemia. Boston Scientific Corporation sponsors the most, 3.

CMS Open Payments shows 421 general payments to Dr. Babaev from 28 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 54% of the total. Boston Scientific Corporation paid the most, $72,553. It also lists 1 research payment totaling $4,500 in 2016.

Dmand AI lists 5 awards for Dr. Babaev, most recently CMS Stage 1 EHR in 2013.

Dr. Babaev graduated from Tajik State Medical University in 1984. Dr. Babaev is a member of ACC.

Dr. Babaev is in network with 19 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.